Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

As a Woman

Post Birth Control Syndrome

28 Aug 2022

Description

Dr. Natalie Crawford discusses Chrissy Teigen and her vulnerability in sharing her fertility journey. Later, she explains the birth control pill and post-birth control syndrome—what it is and why people say it exists. There is a lot of misinformation about the birth control pill, and you should be able to make an informed decision about if it’s the right contraceptive for you.    Finally, Natalie answers your social media questions during her segment FFS—For Fertility’s Sake. This time, all about the pill! I was told the pill causes vitamin deficiencies, and I would need to purchase a post-birth control syndrome cleanse—is that true? What are the side effects and risks of taking the pill? Why did my doctor prescribe birth control after I was diagnosed with an ovarian cyst?  Don't forget to ask your questions on Instagram for next week’s For Fertility’s Sake segment when you see the question box on Natalie’s page @nataliecrawfordmd. You can also ask a question by calling in and leaving a voicemail! Call 657–229–3672 and ask your fertility question today.         Thanks to our amazing sponsor! Check out this deal just for you:      Figs — Go to wearFIGS.com and use code ASAWOMAN to get 15% off your first order.             If you haven’t already, please rate, review, and follow the podcast to be notified of new episodes every Sunday. Plus, be sure to follow along on Instagram @nataliecrawfordmd, check out Natalie's YouTube channel Natalie Crawford MD, and if you're interested in becoming a patient, check out Fora Fertility.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.